BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30851907)

  • 1. Evolution and predictive factors of quality of life in patients undergoing oncologic surgery for head and neck cancer: A prospective multicentric study.
    Bozec A; Schultz P; Gal J; Chamorey E; Chateau Y; Dassonville O; Poissonnet G; Demard F; Peyrade F; Saada E; Benezery K; Leysalle A; Santini L; Messaoudi L; Fakhry N
    Surg Oncol; 2019 Mar; 28():236-242. PubMed ID: 30851907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the information given to patients undergoing head and neck cancer surgery using the EORTC QLQ-INFO25 questionnaire: A prospective multicentric study.
    Bozec A; Schultz P; Gal J; Chamorey E; Chateau Y; Dassonville O; Poissonnet G; Santini J; Peyrade F; Saada E; Guigay J; Benezery K; Leysalle A; Santini L; Giovanni A; Messaoudi L; Fakhry N
    Eur J Cancer; 2016 Nov; 67():73-82. PubMed ID: 27616438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
    Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term quality of life and psycho-social outcomes after oropharyngeal cancer surgery and radial forearm free-flap reconstruction: A GETTEC prospective multicentric study.
    Bozec A; Demez P; Gal J; Chamorey E; Louis MY; Blanchard D; De Raucourt D; Merol JC; Brenet E; Dassonville O; Poissonnet G; Santini J; Peyrade F; Benezery K; Lesnik M; Berta E; Ransy P; Babin E
    Surg Oncol; 2018 Mar; 27(1):23-30. PubMed ID: 29549900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor site and disease stage as predictors of quality of life in head and neck cancer: a prospective study on patients treated with surgery or combined therapy with surgery and radiotherapy or radiochemotherapy.
    Veldhuis D; Probst G; Marek A; Noack V; Ural A; Adamietz I; Dazert S; Minovi A
    Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):215-24. PubMed ID: 25575842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the information given to patients undergoing total pharyngolaryngectomy and quality of life: a prospective multicentric study.
    Bozec A; Schultz P; Gal J; Chamorey E; Chateau Y; Dassonville O; Poissonnet G; Peyrade F; Saada E; Guigay J; Benezery K; Leysalle A; Santini L; Giovanni A; Messaoudi L; Fakhry N
    Eur Arch Otorhinolaryngol; 2019 Sep; 276(9):2531-2539. PubMed ID: 31240456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
    Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
    Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Kim SA; Roh JL; Lee SA; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Cancer; 2016 Jan; 122(1):131-40. PubMed ID: 26371775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The personality and quality of life in HNSCC patients following treatment.
    Aarstad HJ; Aarstad AK; Birkhaug EJ; Bru E; Olofsson J
    Eur J Cancer; 2003 Sep; 39(13):1852-60. PubMed ID: 12932662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.
    Aarstad HJ; Østhus AA; Aarstad HH; Lybak S; Aarstad AKH
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3495-3505. PubMed ID: 31529149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsurgical head and neck reconstruction after oncologic ablation: a study analyzing health-related quality of life.
    Momeni A; Kim RY; Kattan A; Lee GK
    Ann Plast Surg; 2013 Apr; 70(4):462-9. PubMed ID: 23486123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplastic therapy.
    Oliveira KG; von Zeidler SV; Podestá JR; Sena A; Souza ED; Lenzi J; Bissoli NS; Gouvea SA
    BMC Cancer; 2014 Jan; 14():39. PubMed ID: 24460780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer.
    Pierre CS; Dassonville O; Chamorey E; Poissonnet G; Ettaiche M; Santini J; Peyrade F; Benezery K; Sudaka A; Bozec A
    Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):801-7. PubMed ID: 23771320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amount of treatment versus quality of life in patients formerly treated for head and neck squamous cell carcinomas.
    Aarstad HJ; Aarstad AK; Lybak S; Monge O; Haugen DF; Olofsson J
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):9-15. PubMed ID: 16205902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy.
    Fang FM; Chien CY; Kuo SC; Chiu HC; Wang CJ
    Acta Oncol; 2004; 43(6):571-8. PubMed ID: 15370615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
    Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
    Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life.
    Derks W; De Leeuw JR; Hordijk GJ; Winnubst JA
    Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):399-405. PubMed ID: 12969340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of radiotherapy on the quality of life in patients with early-stage clinical head and neck cancer.
    Milecki J; Żmijewska-Tomczak M; Osmola K; Wierzbicka M
    Otolaryngol Pol; 2021 May; 75(5):1-8. PubMed ID: 34552020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in long-term survivors of oropharynx carcinoma.
    Pourel N; Peiffert D; Lartigau E; Desandes E; Luporsi E; Conroy T
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):742-51. PubMed ID: 12377326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.